GigaGen Wins Grant for Immune Repertoire Sequencing Technology

SAN FRANCISCO, CA – GigaGen has won a Phase II Small Business Innovation Research (SBIR) grant for $950K from the National Cancer Institute (NCI). The funds will be used to develop and commercialize molecular kits for immune repertoire sequencing.